Title
Trauma and posttraumatic stress disorder in Japan: Results from the World Mental Health Japan Survey
Date Issued
01 January 2014
Access level
open access
Resource Type
journal article
Author(s)
Kawakami N.
Tsuchiya M.
Umeda M.
Koenen K.C.
Kessler R.C.
Publisher(s)
Elsevier Ltd
Abstract
The purpose of the study was to report the prevalence of trauma exposure and PTSD, conditional risk of PTSD associated with each trauma exposure in the community population in Japan. An interview survey was conducted of a random sample of adult residents in 11 communities of Japan. Among 4134 respondents (response rate, 55%), data from those who completed the part 2 interview (n=1682) were analyzed with a weight for this subsample. Lifetime experiences of 27 trauma events and PTSD were assessed using the WHO-Composite International Diagnostic Interview version 3.0. Sixty percent of the part 2 sample reported exposure to at least one lifetime traumatic event. Lifetime and 12-month PTSD prevalences were 1.3% and 0.7%, respectively. Percentage of all months lived with PTSD in the population was predominantly accounted for by physical/sexual assaults and having a child with serious illness, and unexpected death of loved one. Ten percent of respondents reported "private events", for which respondents did not have to describe the content, which accounted for 19% of months with PTSD. The lower prevalence of PTSD in Japan seems attributable to lower conditional risks of PTSD following these events, as well as different distributions of the events. The greater impact of events that occurred to loved ones rather than to oneself and "private events" on PTSD in Japan warrants further research of cross-cultural assessment of trauma exposure and cultural heterogeneity in the trauma-PTSD relationship. © 2014.
Start page
157
End page
165
Volume
53
Issue
1
Language
English
OCDE Knowledge area
Psiquiatría Políticas de salud, Servicios de salud
Scopus EID
2-s2.0-84897460498
PubMed ID
Source
Journal of Psychiatric Research
ISSN of the container
00223956
Sponsor(s)
The WMH Japan 2002–2006 Survey was supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labour, and Welfare ( H13-SHOGAI-023 , H14-TOKUBETSU-026 , H16-KOKORO-013 , H19-KOKORO-IPPAN-011 , H20-KOKORO-IPPAN-009 ). The survey was carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative which is supported by the National Institute of Mental Health (NIMH; R01 MH070884 and R01 MH093612-01 ), the John D. and Catherine T. MacArthur Foundation , the Pfizer Foundation , the US Public Health Service ( R13-MH066849 , R01-MH069864 , and R01 DA016558 ), the Fogarty International Center ( FIRCA R03-TW006481 ), the Pan American Health Organization , Eli Lilly and Company , Ortho-McNeil Pharmaceutical , GlaxoSmithKline , and Bristol-Myers Squibb . We thank the staff of the WMH Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork, and consultation on data analysis. None of the funders had any role in the design, analysis, interpretation of results, or preparation of this paper. A complete list of all within-country and cross-national WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/ .
Sources of information: Directorio de Producción Científica Scopus